| Website | inimexpharma.com |
| Category | BioTech |
| Phone | (604) 225-2251 |
| info@inimexpharma... | |
| Employees | |
| Description | Innate Defense Regulators |
| TOTAL | $26.5M |
| FUNDING TOTAL | $26.5M |
| Series A, 7/04 BDC Venture Capital Canadian Medical Discoveries Fund GrowthWorks Capital | $4.5M |
| Series B, 6/08 Canadian Medical Discoveries Fund Astellas Venture Management Morningside Group Roche Venture Fund B.C. Advantage Funds Discovery Capital BDC Venture Capital GrowthWorks Capital | $22M |
Inimex Pharmaceuticals, Inc. is a clinical stage company focused on the development and commercialization of Innate Defense Regulators (IDRs), novel first in class drugs that selectively trigger the body’s innate defenses without causing inflammation.
